Trademarkia Logo

Australia

AU$
ONPATTRO
Protected: Registered/protected

Last updated on 30 Jul 2020

Owner Info

Alnylam Pharmaceuticals, Inc.

300 Third Street

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

1803896 filed on 28 Jul 2016

Correspondent

Timothy H. Hiebert

Womble Bond Dickinson (US) LLP,

470 Atlantic Avenue, Suite 600,

UNITED STATES OF AMERICA

ONPATTRO

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; pharmaceutical preparations for the treatment of familial amyloid Read More

Mark Details


Serial Number

1803896

Registered On

28 Jul 2016

Renewal On

28 Jul 2026

Mark Type

WORD

Priority Claim (Convention Details)


Date

18 Mar 2016

Mark Type

US

Legal History


Show more

Status DateAction Taken
30th Jul 2020Amendment to International Registration Contact Requested
2th Feb 2017IP Right Registration Published
25th Jan 2017Register Trade Mark
25th Jan 2017Application Status
17th Nov 2016IP Right Acceptance Published
9th Nov 2016Clear Examination report approved
9th Nov 2016User Created Notice correspondence sent
9th Nov 2016Application Accepted correspondence sent
27th Oct 2016IP Right Filed Published
21st Oct 2016Application Status